Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies
Runzhe Chen, Fei Wang, Hongming Zhang, Baoan ChenDepartment of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People’s Republic of ChinaBackground: Recently, brentuximab vedotin has b...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/brentuximab-vedotin-for-treatment-of-relapsed-or-refractory-malignant--peer-reviewed-article-DDDT |